[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-328563-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-328563-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","global-burden-of-gynaecological-cancers-in-2022-and-projections-to-2050","Global burden of gynaecological cancers in 2022 and projections to 2050","","The incidence and mortality of gynaecological cancers substantially affect women’s quality of life and increase global health care burden. This study evaluates worldwide inequalities in 2022 incidence and deaths using GLOBOCAN 2022 estimates and projects the future burden through 2050. It analyzes total and subtype-specific cases and deaths by region and Human Development Index.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/global-burden-of-gynaecological-cancers-in-2022-and-projections-to-2050/328563/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/global-burden-of-gynaecological-cancers-in-2022-and-projections-to-2050/328563.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of the study?","Question",{"text":63,"@type":64},"To evaluate global inequalities in the incidence and mortality of gynaecological cancers in 2022 and to project the future burden to 2050.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data source and framework are used for 2022 estimates?",{"text":68,"@type":64},"Total cases and deaths for gynaecological cancers, including different subtypes, are taken from the GLOBOCAN database for the year 2022.",{"name":70,"@type":61,"acceptedAnswer":71},"What projections are made for the coming decades?",{"text":72,"@type":64},"If current trends in morbidity and mortality persist, the number of new cases and deaths from female reproductive tract tumours is expected to increase over the next two decades.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},328563,1790698918,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Electronic  \nThe online  \nsupplementary material:  \nversion of this article contains supplementary material.  \n© 2024 The Author(s)  \nCite as: Zhu B, Gu H, Mao Z, Beeraka NM, Zhao X, P A Mahesh, Zheng Y, Zhao R, Li S, Manogaran P, Fan R, Nikolenko VN, Wen H, Basappa B, Liu J. Global burden of gynaecological cancers in 2022 and projections to 2050. J Glob Health 2024;14:04155 .  \nGlobal burden of gynaecological cancersin 2022 and projections to 2050  \nBinhua Zhu1*, Hao Gu1,2*, Zhihan Mao3*, Narasimha MBeeraka4,6,7, Xiang Zhao1, Mahesh Padukudru Anand5, Yufei Zheng1,2, Ruiwen Zhao1,2, Siting Li1,2, Prasath Manogaran8,9, Ruitai Fan1,2, Vladimir N Nikolenko7, Haixiao Wen10, Basappa Basappa11, Junqi Liu1,2  \n1Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China  \n2Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China  \n3Henan Medical College, Zhengzhou University, Zhengzhou, China 4Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu, Chiyyedu, Andhra Pradesh, India  \n5Department of Pulmonary Medicine, JSS Medical College, JSS Academy of Higher Education & Research (JSS AHER), Mysuru, Karnataka, India 6Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA 7Department of Human Anatomy and Histology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation 8Department of Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India  \n9Department of Clinical and Translational Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA 10Department of Gynecologic Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China  \n11Laboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, Mysore, Karnataka, India  \n*Equal contribution.  \nCorrespondence to:  \nProf Junqi Liu, MD, Ph.D.  \nCancer Center, The First Affiliated Hospital of Zhengzhou University No. 1, Jianshe East Road, Erqi District, Zhengzhou, Henan Province PR China  \n[fccliujq@zzu.edu.cn](fccliujq@zzu.edu.cn)  \nProf Narasimha M Beeraka, MRes, Ph.D.  \nDepartment of Human Anatomy and Histology, I.M. Sechenov First Moscow State Medical University (Sechenov University)  \n8/2 Trubetskaya Street, Moscow Russian Federation [bnmurthy24@gmail.com](bnmurthy24@gmail.com)[biraka_n@staff.sechenov.ru](biraka_n@staff.sechenov.ru)  \nBackground The incidence and mortality of gynaecological cancers can significantly impact women’s quality of life and increase the health care burden for organisations globally. The objective of this study was to evaluate global inequalities in the incidence and mortality of gynaecological cancers in 2022, based on The Global Cancer Observatory (GLOBOCAN) 2022 estimates. The future burden of gynaecological cancers (GCs) in 2050 was also projected.  \nMethods Data regarding to the total cases and deaths related to gynaecological cancer, as well as cases and deaths pertaining to different subtypes of GCs, gathered from the GLOBOCAN database for the year 2022. Predictions for the number of cases and deaths in the year 2050 were derived from global demographic projections, categorised by world region and Human Development Index (HDI).  \nResults In 2022, there were 1 473 427 new cases of GCs and 680 372 deaths. The incidence of gynecological cancer reached 30.3 per 100 000, and the mortality rate hit 13.2 per 100 000. The age-standardised incidence of GCs in Eastern Africa is higher than 50 per 100 000, whereas the age-standardised incidence in Northern Africa is 17.1 per 100 000. The highest mortality rates were found in East Africa (ASMR (age-standardised mortality rates) of 35.3 per 100 000) and the lowest in Australia and New Zealand (ASMR of 8.1 per 100 000). These are related to the endemic areas of HIV and HPV. Very H","cbCaiblWcIIXMfOS","https://ap.wps.com/l/cbCaiblWcIIXMfOS","pdf",6773840,28,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Scope of gynaecological cancers","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To evaluate global inequalities in the incidence and mortality of gynaecological cancers in 2022 and to project the future burden to 2050.\"},{\"question\":\"What data source and framework are used for 2022 estimates?\",\"answer\":\"Total cases and deaths for gynaecological cancers, including different subtypes, are taken from the GLOBOCAN database for the year 2022.\"},{\"question\":\"What projections are made for the coming decades?\",\"answer\":\"If current trends in morbidity and mortality persist, the number of new cases and deaths from female reproductive tract tumours is expected to increase over the next two decades.\"}]","Global burden of gynaecological cancers in 2022 and projections to 2050 | PDF",1789980226,71]